Plaintiffs file second amended US antitrust complaint against Teva over EpiPen, Nuvigil
MLex Summary: Plaintiffs filed their second amended US class action complaint accusing Teva Pharmaceuticals of illegally conspiring to block access to generic versions of the EpiPen and the wakefulness drug Nuvigil....To view the full article, register now.
Already a subscriber? Click here to view full article